The Canada Foundation for Innovation (CFI) has granted joint McGill University and Université de Montréal project “Structural biology at the crossroads of biology and medicine”, led by Dr. Kalle Gehring (Department of Biochemistry, Faculty of Medicine), $4,834,000 to help fund continued research. The extra funding should lead to a better understanding of the origins of diseases such as cancer and to the design of novel molecules for use in structure-based drug design and green chemistry. In addition, the funds from CFI will be matched by contributions made by the government of Quebec. Three McGill research projects in all will share close to $11 million in awards from the CFI, based on their most recent announcement.
The government of Canada created the CFI in 1997 to build Canada’s capacity to undertake world-class research and technology development to benefit Canadians. The LOF is designed to help researchers acquire the infrastructure needed to carry out innovative research.
“Research and innovation is a forceful driver of growth in our communities,” said Gilles G. Patry, president and CEO of the Canada Foundation for Innovation. “Today’s funding will allow a talented group of researchers and students to create the solutions, products and ideas Canada needs to prosper.”
“McGill researchers apply their knowledge and imagination towards finding solutions to the problems that face us all,” said Rose Goldstein, Vice-Principal (Research and International Relations) at McGill. “Whether they are looking for ways to detect disease earlier on, developing more efficient nanoelectronics, or working to design better drugs, the support of the Canada Foundation for Innovation is essential to this research and we are very grateful for it.”
January 18, 2013